FindTrial
Sign In

PROSPECTIVE, RANDOMIZED, DUOBLE BLIND COMPARISON BETWEEN SUBARACNOID ANAESTHESIA AND SUBARACNOID ANAESTHESIA WITH BLOCK OF FEMORAL NERVE IN PATIENTS UNDERGOING SURGERY FOR ANTERIOR LIGAMENT REPAIR. - ND

PROSPECTIVE, RANDOMIZED, DUOBLE BLIND COMPARISON BETWEEN SUBARACNOID ANAESTHESIA AND SUBARACNOID ANAESTHESIA WITH BLOCK OF FEMORAL NERVE IN PATIENTS UNDERGOING SURGERY FOR ANTERIOR LIGAMENT REPAIR. - ND

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-000421-21-IT
Enrollment
40
Registered
2007-03-07
Start date
2007-02-20
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PATIENTS UNDERGOING SURGERY FOR CRUSADER ANTERIOR LIGAMENT MedDRA version: 9.1 Level: SOC Classification code 10028395 Term: Musculoskeletal and connective tissue disorders

Interventions

Trade Name: BUPIVACAINA ANG. Pharmaceutical Form: Solution for injection Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Trade Name: MORFINA CLORIDR Pharmace

Sponsors

OSPEDALE S. RAFFAELE
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: PATIENTS UNDERGOING SURGERY FOR CRUSADER ANTERIOR LIGAMENT Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: pregnancy;patients affected by neuropaties; patients not qualified for subaracnoid anaesthesia coagulation problems,previous surgery to the back lumbar region ;ipersensibility to ketoprofene

Design outcomes

Primary

MeasureTime frame
Main Objective: TO COMPARE THE POSTOPERATIVE ANALGESIA BETWEEN SUBARACNOID ANAESTHESIA WITH BUPIVACAIN AND LOW MORPHINE DOSES AND SUBARACNOID ANAESTHESIA WITH BUPIVACAIN AND FEMORAL NERVE BLOCK WITH LEVOBUPIVACAINE.;Secondary Objective: X;Primary end point(s): TO COMPARE THE POSTOPERATIVE ANALGESIA BETWEEN SUBARACNOID ANAESTHESIA WITH BUPIVACAIN AND LOW MORPHINE DOSES AND SUBARACNOID ANAESTHESIA WITH BUPIVACAIN AND FEMORAL NERVE BLOCK WITH LEVOBUPIVACAINE.—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026